"Receptors, CCR4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
CCR receptors with specificity for CHEMOKINE CCL17 and CHEMOKINE CCL22. They are expressed at high levels in T-LYMPHOCYTES; MAST CELLS; DENDRITIC CELLS; and NK CELLS.
| Descriptor ID |
D054398
|
| MeSH Number(s) |
D12.776.543.750.695.160.150.400 D12.776.543.750.705.852.125.150.400
|
| Concept/Terms |
Receptors, CCR4- Receptors, CCR4
- CC Chemokine Receptor 4
- CCR4 Receptor
- Receptor, CCR4
- Antigens, CD194
- CCR4 Receptors
- CD194 Antigens
- CC Chemokine Receptors 4
- CD194 Antigen
- Antigen, CD194
|
Below are MeSH descriptors whose meaning is more general than "Receptors, CCR4".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Chemokine [D12.776.543.750.695.160]
- Receptors, CCR [D12.776.543.750.695.160.150]
- Receptors, CCR4 [D12.776.543.750.695.160.150.400]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CCR [D12.776.543.750.705.852.125.150]
- Receptors, CCR4 [D12.776.543.750.705.852.125.150.400]
Below are MeSH descriptors whose meaning is more specific than "Receptors, CCR4".
This graph shows the total number of publications written about "Receptors, CCR4" by people in this website by year, and whether "Receptors, CCR4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, CCR4" by people in Profiles.
-
Characterization of T lymphocytes in severe COVID-19 patients. J Med Virol. 2021 09; 93(9):5608-5613.
-
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection. Eur J Immunol. 2021 06; 51(6):1436-1448.
-
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4). Clin Microbiol Infect. 2018 Jun; 24 Suppl 2:S83-S94.
-
Role of LAP+CD4+ T cells in the tumor microenvironment of colorectal cancer. World J Gastroenterol. 2017 Jan 21; 23(3):455-463.
-
In Silico Adjuvant Design and Validation. Methods Mol Biol. 2017; 1494:107-125.